152 related articles for article (PubMed ID: 34924268)
21. Osteonecrosis of the jaw in patients with inflammatory bowel disease treated with tumour necrosis factor alpha inhibitors.
Brijs K; Miclotte I; Vermeire S; Darche V; Politis C
Int J Oral Maxillofac Surg; 2020 Mar; 49(3):317-324. PubMed ID: 31466830
[TBL] [Abstract][Full Text] [Related]
22. Serum C-terminal cross-linking telopeptide level as a predictive biomarker of osteonecrosis after dentoalveolar surgery in patients receiving bisphosphonate therapy: Systematic review and meta-analysis.
Awad ME; Sun C; Jernigan J; Elsalanty M
J Am Dent Assoc; 2019 Aug; 150(8):664-675.e8. PubMed ID: 31256803
[TBL] [Abstract][Full Text] [Related]
23. Differences in the Knowledge and Experience of Physicians and Dentists About Medication-Related Osteonecrosis of the Jaw in Osteoporotic Patients.
Yamori M; Tamura M; Mikami M; Mori T; Noi M; Machida Y; Koshinuma S; Yamamoto G
Int Dent J; 2021 Aug; 71(4):336-342. PubMed ID: 33518370
[TBL] [Abstract][Full Text] [Related]
24. Microarchitecture of medication-related osteonecrosis of the jaw (MRONJ); a retrospective micro-CT and morphometric analysis.
Schoenhof R; Munz A; Yuan A; ElAyouti A; Boesmueller H; Blumenstock G; Reinert S; Hoefert S
J Craniomaxillofac Surg; 2021 Jun; 49(6):508-517. PubMed ID: 33707134
[TBL] [Abstract][Full Text] [Related]
25. Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review.
Kawahara M; Kuroshima S; Sawase T
Int J Implant Dent; 2021 May; 7(1):47. PubMed ID: 33987769
[TBL] [Abstract][Full Text] [Related]
26. Do various imaging modalities provide potential early detection and diagnosis of medication-related osteonecrosis of the jaw? A review.
Wongratwanich P; Shimabukuro K; Konishi M; Nagasaki T; Ohtsuka M; Suei Y; Nakamoto T; Verdonschot RG; Kanesaki T; Sutthiprapaporn P; Kakimoto N
Dentomaxillofac Radiol; 2021 Sep; 50(6):20200417. PubMed ID: 33411572
[TBL] [Abstract][Full Text] [Related]
27. Comparing the Influence of Surgical and Conservative Therapy on Quality of Life in Patients with Early-Stage Medication-Related Osteonecrosis of the Jaw-A Prospective Longitudinal Study.
Rückschloß T; Smielowski M; Moratin J; Schnug G; Appel M; Muench P; Bleymehl M; Zittel S; Engel M; Hoffmann J; Ristow O
Medicina (Kaunas); 2023 Jan; 59(2):. PubMed ID: 36837478
[No Abstract] [Full Text] [Related]
28. Pharmacogenetics of medication-related osteonecrosis of the jaw: a systematic review and meta-analysis.
Guo Z; Cui W; Que L; Li C; Tang X; Liu J
Int J Oral Maxillofac Surg; 2020 Mar; 49(3):298-309. PubMed ID: 31445964
[TBL] [Abstract][Full Text] [Related]
29. A comparative effectiveness pilot study of teriparatide for medication-related osteonecrosis of the jaw: daily versus weekly administration.
Ohbayashi Y; Iwasaki A; Nakai F; Mashiba T; Miyake M
Osteoporos Int; 2020 Mar; 31(3):577-585. PubMed ID: 31768589
[TBL] [Abstract][Full Text] [Related]
30. What is the effect of anti-resorptive drugs (ARDs) on the development of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: A systematic review.
Aljohani S; Fliefel R; Ihbe J; Kühnisch J; Ehrenfeld M; Otto S
J Craniomaxillofac Surg; 2017 Sep; 45(9):1493-1502. PubMed ID: 28687467
[TBL] [Abstract][Full Text] [Related]
31. [Interpretation of medication-related osteonecrosis of the jaw: MASCC/ISOO/ASCO clinical practice guideline].
Chen H; He Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2022 Feb; 57(2):128-135. PubMed ID: 35152647
[TBL] [Abstract][Full Text] [Related]
32. Medication-related osteonecrosis of the jaw: Osteoclast profile in comparison with osteoradionecrosis of the jaw and osteomyelitis of the jaw.
Ngoc Thuy Tran V; Chaisuparat R
J Oral Pathol Med; 2021 Aug; 50(7):731-740. PubMed ID: 34038006
[TBL] [Abstract][Full Text] [Related]
33. Histologic analysis of medication-related osteonecrosis of the jaw compared with antiresorptive-exposed bone and other infectious, inflammatory, and necrotic jaw diseases.
Yuan A; Munz A; Reinert S; Hoefert S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Feb; 129(2):133-140. PubMed ID: 31606424
[TBL] [Abstract][Full Text] [Related]
34. Recurrence-Related Factors of Medication-Related Osteonecrosis of the Jaw: A Five-Year Experience.
Chen S; Ren H; He Y; An J; Zhang Y
J Oral Maxillofac Surg; 2021 Dec; 79(12):2472-2481. PubMed ID: 34481810
[TBL] [Abstract][Full Text] [Related]
35. Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention.
Owosho AA; Liang STY; Sax AZ; Wu K; Yom SK; Huryn JM; Estilo CL
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):440-445. PubMed ID: 29580668
[TBL] [Abstract][Full Text] [Related]
36. Medication-related osteonecrosis of the jaw. Implant presence-triggered osteonecrosis: Case series and literature review.
Escobedo MF; Cobo JL; Junquera S; Milla J; Olay S; Junquera LM
J Stomatol Oral Maxillofac Surg; 2020 Feb; 121(1):40-48. PubMed ID: 31035023
[TBL] [Abstract][Full Text] [Related]
37. Medication-related osteonecrosis of the jaw (MRONJ) and eNOS Polymorphisms in multiple myeloma patients: a single center experience.
Taş Ozyurtseven B; Serin I; Nursal AF; Pehlivan S; Pehlivan M
BMC Oral Health; 2021 May; 21(1):272. PubMed ID: 34006261
[TBL] [Abstract][Full Text] [Related]
38. Medication-related osteonecrosis of the jaws associated with intravitreal administration of ranibizumab.
Oz I; Kaplan I; Kleinman S; Arbel S; Shuster A
Int J Oral Maxillofac Surg; 2020 Dec; 49(12):1589-1591. PubMed ID: 32616306
[TBL] [Abstract][Full Text] [Related]
39. Teriparatide Promotes Bone Healing in Medication-Related Osteonecrosis of the Jaw: A Placebo-Controlled, Randomized Trial.
Sim IW; Borromeo GL; Tsao C; Hardiman R; Hofman MS; Papatziamos Hjelle C; Siddique M; Cook GJR; Seymour JF; Ebeling PR
J Clin Oncol; 2020 Sep; 38(26):2971-2980. PubMed ID: 32614699
[TBL] [Abstract][Full Text] [Related]
40. The Prevention of Medication-related Osteonecrosis of the Jaw.
Poxleitner P; Engelhardt M; Schmelzeisen R; Voss P
Dtsch Arztebl Int; 2017 Feb; 114(5):63-69. PubMed ID: 28241916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
